During the past decade, Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika" are "Pulmonary Arterial Hypertension" (3 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials), "Familial Primary Pulmonary Hypertension" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika" in a lesser frequency.

Most popular intervention types in "Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ralinepag" (2 trials), "APD811" (1 trials), "Injection of C3BS-CQR-1" (1 trials) and "Sham, no injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pécsi Tudományegyetem Klinikai Központ - Szívgyógyászati Klinika, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".